MENU

Shattuck Lecturer Speaker Bios

Jeffrey M. Drazen, MDJeffrey M. Drazen, MD, Editor-in-Chief, New England Journal of Medicine

Born and raised in Clayton, Missouri, Dr. Drazen majored in applied physics at Tufts University and graduated from Harvard Medical School in 1972. After serving his medical residency at Peter Bent Brigham Hospital in Boston, he joined its Pulmonary Division and that of the Beth Israel Hospital, serving each as division chair for many years. Through his research, Dr. Drazen defined the role of novel endogenous chemical agents in asthma, leading to four licensed pharmaceuticals for asthma with tens of millions of people on treatment worldwide. In 2000, he assumed the post of editor-in-chief of the New England Journal of Medicine. During his tenure, the Journal has published major papers advancing the science of medicine, including the first descriptions of SARS, timely coverage of the Ebola and Zika virus epidemics, and major advances in the treatment of cancer, heart disease, and lung disease. It has also been at the forefront of the international effort to register all clinical trials and to share clinical trial data. The Journal has over a million and a half readers every week and the highest impact factor of any journal publishing original research.  

John H. Noseworthy, MDJohn H. Noseworthy, MD, President and CEO Emeritus, Mayo Clinic

John Noseworthy, M.D., is president and CEO emeritus of Mayo Clinic. Dr. Noseworthy served as president and CEO from 2009 to 2018, leading one of the largest not-for-profit, academic health systems in the U.S., with $12 billion in annual revenues and 68,000 employees. With a focus on caring for patients with serious, complex illnesses, Mayo Clinic operates in five states and cares for more than one million people a year, from all 50 states and nearly 140 countries. Mayo Clinic is currently ranked #1 in the nation by U.S. News and World Report.

Under his leadership as president and CEO, Mayo Clinic transitioned from a holding company to a single operating company, strengthening Mayo’s ability to consistently achieve top decile performance in quality, safety, education, research, fundraising, finance and reputation measures. Mayo Clinic entered a strategic partnership with the state of Minnesota and local and regional government to form Destination Medical Center, an innovative economic development initiative designed to maintain and grow Mayo Clinic, Rochester and the state of Minnesota as a global destination for medicine and health science innovation. Dr. Noseworthy and his leadership team also led efforts to help Mayo Clinic become a leading model for diversity, where all patients and staff feel welcome and included.

Prior to his appointment as CEO in 2009, Dr. Noseworthy was chair of Mayo Clinic’s Department of Neurology, medical director of the Department of Development and vice chair of the Mayo Clinic Rochester Executive Board.

Dr. Noseworthy served as professor in the Department of Neurology. He specialized in multiple sclerosis and spent more than two decades designing and conducting controlled clinical trials. Dr. Noseworthy is the author of more than 150 research papers, chapters, editorials and several books, including the three-volume textbook Neurological Therapeutics: Principles and Practice now in its second edition. He also served as editor-in-chief for Neurology, the official journal of the American Academy of Neurology.

Born in Melrose, Mass., Dr. Noseworthy received his M.D. degree from Dalhousie University in Halifax, Nova Scotia, Canada. He completed his neurology training at Dalhousie University and the University of Western Ontario, and a research fellowship at Harvard Medical School. He joined Mayo Clinic in 1990. He has received the Alumnus of the Year award from Dalhousie University (2005), an honorary doctorate of science degree from the University of Western Ontario (2012) and an honorary doctorate of law from Dalhousie University (2015). Dr. Noseworthy was named an Officer of the Order of the Orange-Nassau (2015) and received the Research!America, Geoffrey Beene Builders of Science Award (2016). Dr. Noseworthy serves as a member of the Merck Board of Directors. He also is a member of the Twin Cities Public Television Board of Trustees and the Minnesota Business Partnership Executive Committee. Dr. Noseworthy is a Health Governor of the World Economic Forum.

Dr. Noseworthy and his wife, Patricia, have two sons, Peter and Mark.

Share on Facebook

Reference Committee Reports

The A-19 reference committee reports are now available.

View Reports »

Delegates’ Handbook/Online Testimony

Click Here to view the Delegates’ Handbook

Testify Now on resolutions and reports

House of Delegates

Learn more about the MMS’ policy-making body, the House of Delegates

Program Brochure 

Download the 2019 Annual Meeting Program Brochure 

Save the Date for These Upcoming Meetings

2019 Annual Meeting - May 2 - 4, 2019, Seaport Hotel and World Trade Center, Boston

Copyright © 2018. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

781-893-4610 | 781-893-3800 | Member Information Hotline: 800-322-2303 x7311